Activity Info

This interactive microlearning module will provide clinicians with the latest research findings relating to smoldering neuroinflammation, the progression of MS disease and disability irrespective of relapse, the existing gaps in current therapeutic approaches, and the evolving science behind the use of BKI inhibitors for the treatment of smoldering MS.